SEC Form 4 · accession 0001179110-17-012351
IMMUNOGEN INC · IMGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anna Berkenblit
Officer — VP & Chief Medical Officer
Period of report
Sep 13, 2017
Accepted (ET)
Sep 18, 2017 · 11:16 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000855654
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 13, 2017 | S | 1,500 | $7.00 | D | 161,800 | D |
Table II — derivative securities
No Table II lines on this filing.